Patent · US Active

HPV particles and uses thereof

US10179168B2 · kind B2 · utility

6Cited by

19References

12Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
Aura Biosciences, Inc. · US

Inventors

Pierre L. Coursaget · Paris, FR
Antoine A. Touzé · Tours, FR
Maxime J. J. Fleury · Tours, FR
Nicolas Combelas · Tours, FR
Elisabet de los Pinos · Brookline, US

Key dates

Filing date	Jun 28, 2017
Grant date	Jan 15, 2019
Priority date	—
Expiry date	Jun 28, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.